Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy

por Childers, Martin K., Bogan, Janet R., Bogan, Daniel J., Greiner, Hansel, Holder, Melanie, Grange, Robert W., Kornegay, Joe N.
Publicado 2012

NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy

por Kornegay, Joe N, Peterson, Jennifer M, Bogan, Daniel J, Kline, William, Bogan, Janet R, Dow, Jennifer L, Fan, Zheng, Wang, Jiahui, Ahn, Mihye, Zhu, Hongtu, Styner, Martin, Guttridge, Denis C
Publicado 2014

MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy

por Barbash, Israel M., Cecchini, Sylvain, Faranesh, Anthony Z., Virag, Tamas, Li, Lina, Yang, Yu, Hoyt, Robert F., Kornegay, Joe N, Bogan, Janet R., Garcia, Luis, Lederman, Robert J., Kotin, Robert M.
Publicado 2012

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures

por Kornegay, Joe N., Bogan, Daniel J., Bogan, Janet R., Dow, Jennifer L., Wang, Jiahui, Fan, Zheng, Liu, Naili, Warsing, Leigh C., Grange, Robert W., Ahn, Mihye, Balog-Alvarez, Cynthia J., Cotten, Steven W., Willis, Monte S., Brinkmeyer-Langford, Candice, Zhu, Hongtu, Palandra, Joe, Morris, Carl A., Styner, Martin A., Wagner, Kathryn R.
Publicado 2016